Maganin ciwon daji ya canza kwanan nan a cikin babbar hanya; daya daga cikin mafi mahimmancin ci gaba an samo shi tare da hanyoyin maganin rigakafi a matakin salula. Cutar sankarar jini ta B-Cell ta bambanta da sauran cututtukan daji na jini saboda al'amuranta na musamman da martani ga jiyya. Wannan yanayin, musamman wanda ke haifar da yaduwar ƙwayoyin lymphocytes B a cikin jini, zai haifar da sababbin hanyoyin tunani game da yaki da cutar da kuma inganta sakamako ga marasa lafiya. Ana ci gaba da gudanar da bincike don fitar da sabbin ayyuka na B-Cell a cikin kula da kowane nau'in jiyya na tushen cututtukan cututtukan da aka keɓance don yin aiki a kan hanyoyin da ke tattare da cutar. Beijing BIOOCUS Biotech Ltd. tana kan gaba a wannan yanayin juyin halitta, yana gudanar da bincike da haɓaka hanyoyin rigakafi na salula, kuma yana da yunƙuri marasa amfani don fuskantar ƙalubalen cutar sankarar jini ta B-Cell. Babban kamfanin fasahar kere-kere a kasar Sin ya kuma yi alfahari da kasancewarsa kamfani mai kima mai cikakken daraja da ke da cibiyar bincike ta mallakar kansa, wurin GMP, dandalin CDMO, da dandalin musayar fasaha. Alkawarin mu ga maganin cutar sankarar jini ta B-Cell ya wuce adadin rayuwa; yana fadadawa don sanya jiyya ya zama mafi jin daɗin gogewa ga marasa lafiya, tare da sabbin dabaru da keɓancewa.